Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
  • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
  • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
  • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
  • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
  • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
  • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
  • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
  • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
  • G01N33/6854—Immunoglobulins
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K39/00—Medicinal preparations containing antigens or antibodies
  • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2800/00—Detection or diagnosis of diseases
  • G01N2800/04—Endocrine or metabolic disorders
  • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2800/00—Detection or diagnosis of diseases
  • G01N2800/24—Immunology or allergic disorders

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Immunology (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Molecular Biology (AREA)
• Organic Chemistry (AREA)
• Hematology (AREA)
• Urology & Nephrology (AREA)
• Biomedical Technology (AREA)
• Biochemistry (AREA)
• General Chemical & Material Sciences (AREA)
• Veterinary Medicine (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Bioinformatics & Cheminformatics (AREA)
• General Physics & Mathematics (AREA)
• Pathology (AREA)
• Biotechnology (AREA)
• Cell Biology (AREA)
• Microbiology (AREA)
• Food Science & Technology (AREA)
• Physics & Mathematics (AREA)
• Analytical Chemistry (AREA)
• Genetics & Genomics (AREA)
• Biophysics (AREA)
• Diabetes (AREA)
• Rehabilitation Therapy (AREA)
• Rheumatology (AREA)
• Endocrinology (AREA)
• Emergency Medicine (AREA)
• Transplantation (AREA)
• Obesity (AREA)
• Cardiology (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=26311906

Family Applications (1)

Country Status (21)

Families Citing this family (15)

Family Cites Families (7)

• 1998
  • 1998-07-20 IL IL13327798A patent/IL133277A0/xx active IP Right Grant
  • 1998-07-20 TR TR2000/00181T patent/TR200000181T2/xx unknown
  • 1998-07-20 CA CA2296842A patent/CA2296842C/en not_active Expired - Fee Related
  • 1998-07-20 SI SI9830782T patent/SI0998556T1/xx unknown
  • 1998-07-20 KR KR1020007000632A patent/KR100567277B1/ko not_active IP Right Cessation
  • 1998-07-20 EP EP05076378A patent/EP1595951A1/en not_active Withdrawn
  • 1998-07-20 DK DK98935160T patent/DK0998556T3/da active
  • 1998-07-20 US US09/463,158 patent/US6689359B1/en not_active Expired - Fee Related
  • 1998-07-20 EP EP98935160A patent/EP0998556B1/en not_active Expired - Lifetime
  • 1998-07-20 JP JP50949099A patent/JP2002511765A/ja not_active Ceased
  • 1998-07-20 NZ NZ501424A patent/NZ501424A/en not_active IP Right Cessation
  • 1998-07-20 PT PT98935160T patent/PT998556E/pt unknown
  • 1998-07-20 WO PCT/GB1998/002151 patent/WO1999005175A2/en active IP Right Grant
  • 1998-07-20 DE DE69830588T patent/DE69830588T2/de not_active Expired - Lifetime
  • 1998-07-20 PL PL338449A patent/PL204503B1/pl not_active IP Right Cessation
  • 1998-07-20 CN CNB988073803A patent/CN1330754C/zh not_active Expired - Fee Related
  • 1998-07-20 AT AT98935160T patent/ATE297983T1/de active
  • 1998-07-20 KR KR1020057007380A patent/KR100670070B1/ko not_active IP Right Cessation
  • 1998-07-20 ES ES98935160T patent/ES2245034T3/es not_active Expired - Lifetime
  • 1998-07-20 EA EA200000146A patent/EA003131B1/ru not_active IP Right Cessation
  • 1998-07-20 BR BR9810118-8A patent/BR9810118A/pt not_active Application Discontinuation
  • 1998-07-20 AU AU84517/98A patent/AU758455B2/en not_active Ceased
• 1999
  • 1999-12-02 IL IL133277A patent/IL133277A/en not_active IP Right Cessation
• 2000
  • 2000-01-18 CU CU20000009A patent/CU23412A3/es not_active IP Right Cessation
• 2003
  • 2003-10-01 US US10/674,433 patent/US20050100541A1/en not_active Abandoned
• 2006
  • 2006-05-31 IL IL176076A patent/IL176076A/en not_active IP Right Cessation

Also Published As

Similar Documents